Cargando…

Can simple Non-Invasive Fibrosis Models Determine Prognostic Indicators (Fibrosis and Treatment Response) of Primary Biliary Cholangitis?

OBJECTIVE: The fibrosis stage during diagnosis and the response to ursodeoxycholic acid in the 1(st) year of treatment are considered to be prognostic indicators in primary biliary cholangitis (PBC). Determining these indicators with non-invasive models can enable the risk of liver failure to be mon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sayar, Suleyman, Gokcen, Pinar, Aykut, Huseyin, Adali, Gupse, Doganay, Hamdi Levent, Ozdil, Kamil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526222/ https://www.ncbi.nlm.nih.gov/pubmed/34712085 http://dx.doi.org/10.14744/SEMB.2021.95825

Ejemplares similares

Acute Severe Ulcerative Colitis After mRNA Coronavirus Disease 2019 Vaccination: Can mRNA Vaccines Unmask Inflammatory Bowel Diseases?
por: Ak, Çağatay, et al.
Publicado: (2022)

Are nucleos(t)ide analogues effective against severe outcomes in COVID-19 and hepatitis B virus coinfection?
por: Adali, Gupse, et al.
Publicado: (2021)

Validation of the PAGE-B score to predict hepatocellular carcinoma risk in caucasian chronic hepatitis B patients on treatment
por: Gokcen, Pinar, et al.
Publicado: (2022)

Prediction of Prognosis Acute Pancreatitis with Inflammatory Markers and Patient Characteristics Compared to the Scoring System: Real-Life Data
por: Ak, Cagatay, et al.
Publicado: (2023)

Can gastric botulinum toxin A injection be used as minimally invasive procedure in the short-term treatment of obesity?
por: Özdil, Kamil, et al.
Publicado: (2022)

Portal vein thrombosis risk factors in liver transplant candidates
por: Ak, Cagatay, et al.
Publicado: (2022)

A practical marker to determining acute severe ulcerative colitis: CRP/albumin ratio
por: Sayar, Suleyman, et al.
Publicado: (2019)

Prevalence and predictors of metabolic-associated fatty liver disease in liver transplant recipients: A cross-sectional prospective study
por: Adali, Gupse, et al.
Publicado: (2023)

CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis
por: Greenman, Raanan, et al.
Publicado: (2023)

The Potential Effects of Diabetes Mellitus on Liver Fibrosis in Patients with Primary Biliary Cholangitis
por: Liu, Xu, et al.
Publicado: (2019)

Telomere dysfunction promotes cholangiocyte senescence and biliary fibrosis in primary sclerosing cholangitis
por: Jalan-Sakrikar, Nidhi, et al.
Publicado: (2023)

Endoscopic retrograde cholangiopancreaticography in elderly patients: A reliable alternative in sepsis
por: Kilic, Ebru Tarikci, et al.
Publicado: (2018)

Host genetic factors affecting hepatitis B infection outcomes: Insights from genome-wide association studies
por: Akcay, Izzet Mehmet, et al.
Publicado: (2018)

Lipid profile, atherogenic indices, and their relationship with epicardial fat thickness and carotid intima–media thickness in celiac disease
por: Caliskan, Zuhal, et al.
Publicado: (2019)

SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease
por: Colak, Yasar, et al.
Publicado: (2011)

Effects of Melittin Treatment in Cholangitis and Biliary Fibrosis in a Model of Xenobiotic-Induced Cholestasis in Mice
por: Kim, Kyung-Hyun, et al.
Publicado: (2015)

DHEA and Its Metabolites Reduce the Cytokines Involved in the Inflammatory Response and Fibrosis in Primary Biliary Cholangitis
por: Blatkiewicz, Małgorzata, et al.
Publicado: (2023)

The effects of obesity on sedation-related outcomes of advanced endoscopic procedures
por: Kilic, Ebru Tarikci, et al.
Publicado: (2019)

The ectonucleotidase ENTPD1/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis
por: Peng, Zhen‐Wei, et al.
Publicado: (2017)

Enhanced liver fibrosis score as a surrogate of liver-related complications and mortality in primary biliary cholangitis
por: Fujinaga, Yukihisa, et al.
Publicado: (2021)

The gamma-glutamyl transferase to platelet ratio for noninvasive evaluation of liver fibrosis in patients with primary biliary cholangitis
por: Avcioğlu, Ufuk, et al.
Publicado: (2022)

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021)

Integrating personalized genomics into Turkish healthcare system: A cancer-oriented pilot activity of Istanbul Northern Anatolian Public Hospitals with GLAB
por: Doganay, Levent, et al.
Publicado: (2017)

Performance of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis-primary biliary cholangitis overlap syndrome
por: Wu, Hui-Min, et al.
Publicado: (2018)

Primary biliary cholangitis associated with drug-induced liver injury and alcoholic liver fibrosis: A case report
por: Sun, Yu, et al.
Publicado: (2018)

High incidence of hepatitis B core antibody positivity in metabolic-associated fatty liver disease-related cirrhosis
por: Ergenc, Ilkay, et al.
Publicado: (2021)

Effect of HLA-DPA1 alleles on chronic hepatitis B prognosis and treatment response
por: Katrinli, Seyma, et al.
Publicado: (2017)

Characteristics of the Gut Microbiome and IL-13/TGF-β1 Mediated Fibrosis in Post-Kasai Cholangitis of Biliary Atresia
por: Meng, Lingdu, et al.
Publicado: (2021)

FGF1 Signaling Modulates Biliary Injury and Liver Fibrosis in the Mdr2(−/−) Mouse Model of Primary Sclerosing Cholangitis
por: O’Brien, April, et al.
Publicado: (2022)

Smoking & risk of advanced liver fibrosis among patients with primary biliary cholangitis: A systematic review & meta-analysis
por: Wijarnpreecha, Karn, et al.
Publicado: (2021)

Choledochoduodenal fistula: An unusual cause of recurrent cholangitis in children
por: Duman, Levent, et al.
Publicado: (2014)

Osteoporosis in primary biliary cholangitis
por: Danford, Christopher J, et al.
Publicado: (2018)

Baricitinib and primary biliary cholangitis
por: Gordon, Stuart C., et al.
Publicado: (2021)

Bile Acids and Biliary Fibrosis
por: Aseem, Sayed Obaidullah, et al.
Publicado: (2023)

Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2(−/−) mice and human primary sclerosing cholangitis
por: Meng, Fanyin, et al.
Publicado: (2018)

Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut‐Off Approach
por: Cristoferi, Laura, et al.
Publicado: (2021)

The Role of Self-Expandable Metallic Stents in the Treatment of Malignant Strictures in all Segments of the Gastrointestinal Tract
por: Çağatay, A. K., et al.
Publicado: (2023)

Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population
por: Alomari, Mohammad, et al.
Publicado: (2019)

Plasma cell-free DNA methylation: a liquid biomarker of hepatic fibrosis
por: Yiğit, Buket, et al.
Publicado: (2018)

Overlap Syndrome between Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Sundaram, Sridhar, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r6cl1lj5v93oh6r2levcpkre9u